ARTICLE | Product Development

Regulating regeneration in Europe

Europe re-examines its regenerative medicine policies

March 22, 2019 1:57 AM UTC

As Europe rethinks its policies on regenerative medicine, the question is whether it can regain its footing in a competitive field it once led, given the in-built inconsistencies across the EU’s member states.

Europe positioned itself early as a leader in regenerative medicine, but the different protocols, requirements and practices between European members states have made the region less attractive for developing regenerative medicines, according to six regenerative medicine company executives who spoke with BioCentury. ...